1.Prevalence of latex allergy in spina bifida patients in Singapore
Xiuzhen CHUA ; Javid MOHAMED ; Hugo PS VAN BEVER
Asia Pacific Allergy 2013;3(2):96-99
BACKGROUND: Latex allergy and its clinical presentation are rising in prevalence across the globe, especially amongst patients with spina bifida (SB). While studies have been well-established in Europe and America, data from Asia are limited. OBJECTIVE: The aim of this study is to investigate the scenario in Singapore. METHODS: 35 subjects with SB, aged 5 to 32 years answered a questionnaire and underwent skin prick test (SPT) using a latex solution, 3 common house dust mites and 3 commonly cross-reacting food allergens (banana, kiwi and avocado). We also noted the relation between latex sensitization with atopy and doctor-diagnosed allergy. The prevalence of cross-reactivity with fruits was also studied. RESULTS: Sensitization to latex (i.e. a positive SPT) was found in 16 (46%, 95% confidence interval 29%-63%) of the subjects. Only 5 (31%) of the subjects who were sensitized to latex had clinical manifestations. Atopy (i.e. positive SPT to house dust mites) was present in 23 (66%) of the subjects and 13 (57%) of them was also sensitized to latex. There was a positive trend between latex sensitization and atopy (81.2% vs. 52.6%, p = 0.076), as well as latex sensitization with those having both atopy and doctor-diagnosed allergy (i.e. asthma, allergic rhinitis, eczema, drug allergy) (93.8% vs. 63.2%, p = 0.032). Only 6 (38%) subjects had allergy to the food allergens tested. CONCLUSION: Almost half of the SB patients in Singapore are sensitized to latex. This number is comparable to that in Europe and America. Positive trend between latex sensitization and those with both atopy and doctor-diagnosed allergy (p = 0.032) is suggestive of a possible cause-effect relationship.
Allergens
;
Americas
;
Asia
;
Asthma
;
Dust
;
Eczema
;
Europe
;
Fruit
;
Humans
;
Hypersensitivity
;
Latex Hypersensitivity
;
Latex
;
Prevalence
;
Pyroglyphidae
;
Rhinitis, Allergic
;
Singapore
;
Skin
;
Spinal Dysraphism
2.Rhinitis in children less than 6 years of age: current knowledge and challenges
Antony HARDJOJO ; Lynette PC SHEK ; Hugo PS VAN BEVER ; Bee Wah LEE
Asia Pacific Allergy 2011;1(3):115-122
Rhinitis is a disease of the upper airway characterized by runny and/or blocked nose and/or sneezing. Though not viewed as a life threatening condition, it is also recognized to impose significant burden to the quality of life of sufferers and their caretakers and imposes an economic cost to society. Through a PubMed online search of the literature from 2006 to September 2011, this paper aims to review the published literature on rhinitis in young children below the age of 6 years. It is apparent from epidemiology studies that rhinitis in this age group is a relatively common problem. The condition has a heterogenous etiology with classification into allergic and non-allergic rhinitis. Respiratory viral infections may play a role in the pathogenesis of long standing rhinitis, but definitive studies are still lacking. Treatment guidelines for management are lacking for this age group, and is a significant unmet need. Although the consensus is that co-morbidities including otitis media with effusion, adenoidal hypertrophy and asthma, are important considerations of management of these children. Pharmacotherapy is limited for young children especially for those below the age of 2 years. This review underscores the lack of understanding of rhinitis in early childhood and therefore the need for further research in this area.
Adenoids
;
Asthma
;
Child
;
Classification
;
Consensus
;
Drug Therapy
;
Epidemiology
;
Humans
;
Hypertrophy
;
Nose
;
Otitis Media with Effusion
;
Prevalence
;
Quality of Life
;
Rhinitis
;
Risk Factors
;
Sneezing
3.Erratum: Rhinitis in children less than 6 years of age: current knowledge and challenges
Antony HARDJOJO ; Lynette PC SHEK ; Hugo PS VAN BEVER ; Bee Wah LEE
Asia Pacific Allergy 2012;2(1):90-90
In the original publication, we created a mistake in typing the name. Thus it was spelled as Antony Hadjojo when submitted to the publisher. We request for a correction of the author name into Antony Hardjojo.
Child
;
Humans
;
Publications
;
Rhinitis
4.Gianotti-Crosti syndrome: case report of a pruritic acral exanthema in a child
Genevieve Villablanca LLANORA ; Clifton Ming TAY ; Hugo PS VAN BEVER
Asia Pacific Allergy 2012;2(3):223-226
Gianotti-Crosti syndrome (GCS) is a sporadic dermatosis affecting mainly children. It is characterized by multiple, confluent, monomorphic and pruritic pink to red-brown papules or papulovesicles, distributed symmetrically on the face, extensor surfaces of the extremities and buttocks, commonly sparing the trunk, palms and soles. This can be preceded by a viral infection, and may be accompanied by fever, hepatosplenomegaly, or lymphadenopathy. Personal and family history of atopy appears to be a risk factor in the subsequent development of GCS, thus frequently diagnosed as atopic dermatitis. We report a case of a 4-year-old boy from our institution with generalized, pruritic, papulovesicular rashes on the face and extremities for one month. He was diagnosed to have atopic dermatitis and treated as such, before presentation to our institution. As the signs and symptoms in GCS are similar to atopic dermatitis, we suggest that this diagnosis be considered when presented with a similar case.
Acrodermatitis
;
Buttocks
;
Child
;
Child, Preschool
;
Dermatitis, Atopic
;
Diagnosis
;
Exanthema
;
Extremities
;
Fever
;
Humans
;
Hypersensitivity
;
Lymphatic Diseases
;
Male
;
Risk Factors
;
Skin Diseases
5.House dust mite sensitization in toddlers predict persistent wheeze in children between eight to fourteen years old
Genevieve V LLANORA ; Low Jia MING ; Lee Ming WEI ; Hugo PS VAN BEVER
Asia Pacific Allergy 2012;2(3):181-186
BACKGROUND: Identifying toddlers at increased risk of developing persistent wheeze provides an opportunity for risk-reducing interventions. House dust mite (HDM) allergen sensitization might identify this group of high-risk children. OBJECTIVE: We examined whether a positive skin prick test (SPT) to at least 1 of the 3 HDMs in wheezing toddlers, would serve as a predictor for persistent wheeze at age 8 to 14 years old. METHODS: A cohort of 78 children, who had wheezing episodes, and underwent SPT to 3 HDMs between the ages of 2 to 5 years old, were enrolled. SPT results were obtained from the National University Hospital database. Four to 9 years later, the children, currently between 8 to 14 years old, were re-assessed for persistence of asthma symptoms and other atopic disorders via a telephone interview. A validated questionnaire on current wheezing and asthma, developed by the International Study of Asthma and Allergies in Childhood, was used. Fisher's exact test was used to evaluate the association between persistence of asthma and a positive SPT. RESULTS: Of the 78 children who participated in the study, 42 (53.8%) had a positive SPT and 36 (46.2%) had a negative SPT. Of these, 18 (42.9%) of SPT positive and 7 (19.4%) of SPT negative children had persistence of asthma symptoms. There is a significant association between a positive SPT during the preschool years, and persistence of asthma (p = 0.0314 [<0.05]). CONCLUSION: HDM sensitization at ages 2 to 5 years old in wheezing children predicts persistence of asthma after 4 to 9 years. This in turn may have benefits for management of asthma in this high-risk group.
Asthma
;
Child
;
Cohort Studies
;
Dust
;
Humans
;
Hypersensitivity
;
Interviews as Topic
;
Pyroglyphidae
;
Respiratory Sounds
;
Skin
;
Skin Tests
6.The methodology of the GUSTO cohort study: a novel approach in studying pediatric allergy
Shu E SOH ; Samuel Shang Ming LEE ; Sarah Wenli HOON ; Mae Yun TAN ; Anne GOH ; Bee Wah LEE ; Lynette Pei Chi SHEK ; Oon Hoe TEOH ; Kenneth KWEK ; Seang Mei SAW ; Keith GODFREY ; Yap Seng CHONG ; Peter GLUCKMAN ; Hugo PS VAN BEVER
Asia Pacific Allergy 2012;2(2):144-148
Growing Up in Singapore Towards healthy Outcomes (GUSTO) is Singapore's largest birth cohort study to date. The main aim of GUSTO is to evaluate the role of developmental factors in the early pathways to metabolic compromise. Detailed data is collected for a range of environmental exposures in the parents and offspring, and allergic disorders are among a number of outcomes assessed in infancy and childhood. Under the Allergy domain of GUSTO, this integrated study will describe the epidemiology of allergic manifestations and different phenotypes in the Asian context and help shed light on the association of metabolic disease to allergy. Epigenetic mechanisms and associations with other childhood disorders will also be explored. The aim of this report is to focus on methodology of GUSTO, and to suggest similar approaches (i.e., integrated cohort studies on pediatric allergy) worldwide. Recruitment commenced in 2009 with a cohort of 1,163 pregnant mothers in their first trimester. The mothers and children were followed throughout pregnancy and follow-up will continue until the child reaches 3 years of age. Preliminary results showed that 39.8% of the mothers had a personal history of having at least one allergic disease, which included asthma, eczema and allergic rhinitis. Further data collection and analyses are still ongoing. Allergy is a complex spectrum of disorders with numerous poorly-understood aspects. The ongoing GUSTO cohort study, with its longitudinal design and multi-disciplinary nature, may provide new insights into developmental influences on allergy. As a Singapore-based study, it will be the first integrated allergy cohort in Southeast Asia, of which recruitment started during pregnancy.
Asia, Southeastern
;
Asian Continental Ancestry Group
;
Asthma
;
Child
;
Cohort Studies
;
Data Collection
;
Eczema
;
Environmental Exposure
;
Epidemiology
;
Epigenomics
;
Female
;
Follow-Up Studies
;
Humans
;
Hypersensitivity
;
Metabolic Diseases
;
Mothers
;
Parents
;
Parturition
;
Phenotype
;
Pregnancy
;
Pregnancy Trimester, First
;
Rhinitis, Allergic
;
Singapore
7.Relationship between all fevers or fever after vaccination, and atopy and atopic disorders at 18 and 36 months
Hong Hui WONG ; Jaslyn Jie Lin LEE ; Lynette Pei Chi SHEK ; Bee Wah LEE ; Anne GOH ; Oon Hoe TEOH ; Peter D GLUCKMAN ; Keith M GODFREY ; Seang Mei SAW ; Kenneth KWEK ; Yap Seng CHONG ; Hugo PS VAN BEVER
Asia Pacific Allergy 2016;6(3):157-163
BACKGROUND: Studies have reported that early febrile episodes and febrile episodes with infections are associated with a decreased risk of developing atopy. OBJECTIVE: To examine further the association between presence of and number of febrile episodes are with atopy and atopic diseases and if there was a difference between all fevers and fever after vaccination. METHODS: We studied 448 infants in a Singapore mother-offspring cohort study (Growing Up in Singapore Towards Healthy Outcomes) which had complete data for the exposures and outcomes of interest. Fever was defined as more than 38.0℃ and was self-reported. The presence of and number of febrile episodes were examined for association with outcome measures, namely parental reports of doctor-diagnosed asthma and eczema, and rhinitis, which was evaluated by doctors involved in the study at 18 and 36 months. These outcomes were considered atopic if there were 1 or more positive skin prick tests. RESULTS: The presence of all fevers from 0–6 months of age was associated with reduced odds of having atopy at 36 months of age (unadjusted odds ratio [OR], 0.628; 95% confidence interval [CI], 0.396–0.995). The presence of fever after vaccination from 0–24 months of age was associated with reduced odds of having atopy at 36 months of age (OR, 0.566; 95% CI, 0.350–0.915). The presence of all fevers from 0–6 months of age was associated with reduced odds of having atopic eczema at 36 months (OR, 0.430; 95% CI, 0.191–0.970). Fever was associated with increased odds of having doctor-diagnosed asthma and rhinitis. CONCLUSION: There was an inverse relationship between the presence of all fevers from 0–6 months of age and the development of atopy and eczema at 36 months of age. Fever after vaccination might be considered a subclinical infection that did not show the same effect in early life.
Asthma
;
Asymptomatic Infections
;
Cohort Studies
;
Dermatitis, Atopic
;
Eczema
;
Fever
;
Humans
;
Infant
;
Odds Ratio
;
Outcome Assessment (Health Care)
;
Parents
;
Rhinitis
;
Singapore
;
Skin
;
Vaccination
8.Economic value of using partially hydrolysed infant formula for risk reduction of atopic dermatitis in high-risk, not exclusively breastfed infants in Singapore.
Marc F BOTTEMAN ; Abhijeet J BHANEGAONKAR ; Erica G HORODNICEANU ; Xiang JI ; Bee Wah LEE ; Lynette P SHEK ; Hugo Ps Van BEVER ; Patrick DETZEL
Singapore medical journal 2018;59(8):439-448
INTRODUCTIONPrevious trials have demonstrated reductions in atopic dermatitis (AD) incidence when healthy, high-risk, non-exclusively breastfed infants were fed until four months of age with 100% whey-based partially hydrolysed formula (PHF-W) versus standard cow's milk formula (CMF). We assessed the cost-effectiveness of this intervention in Singapore.
METHODSModelling techniques were used to simulate, from birth to Month 30, the incidence and clinical/economic burden of AD in high-risk, non-exclusively breastfed infants fed with PHF-W or CMF for up to four months. Epidemiologic and clinical data were from a local comparative trial. Expert opinion informed AD treatment patterns and outcomes. Outcomes included reduction in AD risk, time spent with AD, days without AD flare, quality-adjusted life years (QALYs) and direct/indirect costs. Multivariate probabilistic sensitivity analysis was used to assess model parameter uncertainty.
RESULTSOver 30 months, with the use of PHF-W instead of CMF, the proportion of children who developed AD and the time spent with AD decreased by 16.0% (28.3% vs. 44.3%) and 6.4 months, respectively, while time without AD flare and QALYs increased by 14.9 days and 0.021 QALYs per patient, respectively. Estimated AD-related discounted costs per child for PHF-W and CMF were SGD 771 and SGD 1,309, respectively (net savings: SGD 538). PHF-W was less expensive and more effective than CMF for 73%, and cost less than SGD 50,000 per QALY for 87% of all multivariate simulations.
CONCLUSIONEarly short-term nutritional intervention with PHF-W instead of CMF may reduce AD incidence and costs for healthy, high-risk, non-exclusively breastfed infants in Singapore.